#52 – Right-Wing Psychedelia at University of Madison-Wisconsin

June 27, 2022

This talk was presented live by Dr. Brian Pace and Dr. Neşe Devenot at the UW–Madison Transdisciplinary Center for Research in Psychoactive Substances. This talk was presented on April 28 as part of the “Psychedelic Humanities” speaker series, organized by Dr. Lucas Richert.

Public discourse concerning psychedelics and the emerging industry in psychedelic-assisted therapy has extended beyond the potential benefits of novel treatments for specific mental health disorders to claims that widespread psychedelic use may tilt social relations towards more egalitarian norms. Researchers and media outlets have pointed to several recent studies which present data asserting that classical psychedelics can reduce authoritarianism, increase liberal views, and deepen nature-relatedness.

Taken together, these studies are cited to promote a vision of drug-assisted social progress. Yet counter examples abound of psychedelic-experienced individuals expressing views explicitly opposed to egalitarianism and liberal politics. Moreover, acceptance of psychedelics by institutions and aspirational business and celebrity figures has only increased right-wing psychedelic interest in recent years.

This presentation highlights the numerous contemporary and historical cases where the use of psychedelics failed to reduce authoritarian tendencies in users, or even facilitated adoption of authoritarian views. We demonstrate that psychedelics can catalyze change in political or religious belief, but not in a consistent direction. Instead, we propose that many transformative experiences—including those induced by psychedelics—can challenge and radically shift a person’s worldview, and that extra-pharmacological factors influence the character of change in ideology or political belief.

#52 – Right-Wing Psychedelia at University of Madison-Wisconsin

This talk was presented live by Dr. Brian Pace and Dr. Neşe Devenot at the UW–Madison Transdisciplinary Center for Research in Psychoactive Substances. This talk was presented on April 28 as part of the “Psychedelic Humanities” speaker series, organized by Dr. Lucas Richert.

Plus Three|June 27, 2022

Public discourse concerning psychedelics and the emerging industry in psychedelic-assisted therapy has extended beyond the potential benefits of novel treatments for specific mental health disorders to claims that widespread psychedelic use may tilt social relations towards more egalitarian norms. Researchers and media outlets have pointed to several recent studies which present data asserting that classical psychedelics can reduce authoritarianism, increase liberal views, and deepen nature-relatedness.

Taken together, these studies are cited to promote a vision of drug-assisted social progress. Yet counter examples abound of psychedelic-experienced individuals expressing views explicitly opposed to egalitarianism and liberal politics. Moreover, acceptance of psychedelics by institutions and aspirational business and celebrity figures has only increased right-wing psychedelic interest in recent years.

This presentation highlights the numerous contemporary and historical cases where the use of psychedelics failed to reduce authoritarian tendencies in users, or even facilitated adoption of authoritarian views. We demonstrate that psychedelics can catalyze change in political or religious belief, but not in a consistent direction. Instead, we propose that many transformative experiences—including those induced by psychedelics—can challenge and radically shift a person’s worldview, and that extra-pharmacological factors influence the character of change in ideology or political belief.

Join Our Newsletter

Independent reporting. Critical analysis. In your inbox.

Previous episodes


#30 – Giving a F*ck About People Who Use Drugs with Yarelix Estrada

In this episode, we're joined by our new advisory board member Yarelix Estrada to discuss her experiences with organizing psychedelic societies, psychedelic exceptionalism, and harm reduction on the streets of New York. Yarelix shares insights from her formal and practical training in public health as well as her interactions with frontline communities and her personal experiences.

#29 – The Tesla of Mental Health?

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”

#28 – Qoup At The Qapitol: Q’mon Man

In this episode, we discuss a prominent participant in the bumbling coup attempt of January 6: "QAnon Shaman" Jake Angeli. Along with a coalition of Donald Trump supporters and assorted right wing ideologues, Angeli stormed the Capitol following a speech by Trump. Featuring a dissection of an "Ascension Masterclass" that was hosted on Angeli's now-deleted Star Seed Academy Facebook page, we (once again) wade into the disturbing world of psychedelic authoritarianism.

#27 – The Thought Leader and the Critic

This episode explores the rise of self-styled “thought leaders” within the psychedelic community, using Anand Giridharadas’ book “Winners Take All” as a jumping off point. Although people have been on the conference circuit for years, the recent explosion of capital investments means that there’s an unprecedented potential for money, celebrity, and status in the space.

#26 – Livestream: The Gang Goes Non-Profit

We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

#25 – Press Release: Plus Three found to have neuroprotective effects against corporadelic BS

In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.

#24 – From Mining to Mushrooms

Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry. This episode explores the destructive nature of extractive industry and the effects of introducing those dynamics into psychedelia. If the same people destroying Indigenous lands told you they believed in "sacred reciprocity," would you believe them?

#23 – “Grow, Gather, Give” Is an Anti-Capitalist Approach (and That’s a Good Thing)

Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

#22 – Coronavirus Conspiracy Theories in Psychedelia

Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.

#21 – American Trip: Ido Hartogsohn

Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”

Previous episodes


#30 – Giving a F*ck About People Who Use Drugs with Yarelix Estrada

In this episode, we're joined by our new advisory board member Yarelix Estrada to discuss her experiences with organizing psychedelic societies, psychedelic exceptionalism, and harm reduction on the streets of New York. Yarelix shares insights from her formal and practical training in public health as well as her interactions with frontline communities and her personal experiences.

#29 – The Tesla of Mental Health?

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”

#28 – Qoup At The Qapitol: Q’mon Man

In this episode, we discuss a prominent participant in the bumbling coup attempt of January 6: "QAnon Shaman" Jake Angeli. Along with a coalition of Donald Trump supporters and assorted right wing ideologues, Angeli stormed the Capitol following a speech by Trump. Featuring a dissection of an "Ascension Masterclass" that was hosted on Angeli's now-deleted Star Seed Academy Facebook page, we (once again) wade into the disturbing world of psychedelic authoritarianism.

#27 – The Thought Leader and the Critic

This episode explores the rise of self-styled “thought leaders” within the psychedelic community, using Anand Giridharadas’ book “Winners Take All” as a jumping off point. Although people have been on the conference circuit for years, the recent explosion of capital investments means that there’s an unprecedented potential for money, celebrity, and status in the space.

#26 – Livestream: The Gang Goes Non-Profit

We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

#25 – Press Release: Plus Three found to have neuroprotective effects against corporadelic BS

In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.

#24 – From Mining to Mushrooms

Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry. This episode explores the destructive nature of extractive industry and the effects of introducing those dynamics into psychedelia. If the same people destroying Indigenous lands told you they believed in "sacred reciprocity," would you believe them?

#23 – “Grow, Gather, Give” Is an Anti-Capitalist Approach (and That’s a Good Thing)

Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

#22 – Coronavirus Conspiracy Theories in Psychedelia

Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.

#21 – American Trip: Ido Hartogsohn

Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”

Psymposia is a 501(c)(3) non-profit media organization that offers critical perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

Privacy. Terms of Use. © Psymposia, Inc. All Rights Reserved

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1